Elysium Health operates in the life sciences sector, focusing on developing scientifically-backed health products aimed at improving cellular aging, DNA health, and brain function. The company serves health-conscious consumers who are interested in proactive health management and longevity. Elysium Health's business model revolves around direct-to-consumer sales of its flagship products, including Basis, Matter, and Index. Basis is a supplement clinically proven to increase NAD levels, which are essential for cellular health. Matter is designed to slow age-related brain atrophy with a specific B vitamin complex. Index is an at-home test that uses epigenetics technology to determine biological age. The company generates revenue through online sales and subscription models, ensuring a steady stream of income. Elysium Health differentiates itself through its commitment to scientific research and partnerships with leading academic institutions.

Keywords: cellular aging, DNA health, brain function, NAD levels, epigenetics, biological age, supplements, direct-to-consumer, scientific research, longevity.